← Eichor
Condition: Gastrointestinal Stromal Tumor Gist Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Gastrointestinal Stromal Tumor Gist

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
Phase N/A · 1 location(s) · Xinhua Zhang, MD · NCT05464875Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients
NA · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT07673861Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (G
Phase 2 · 13 location(s) · Centre Leon Berard · NCT05009927An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT070721435 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk
Phase 2 · 1 location(s) · Asan Medical Center · NCT05385549Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepat
Phase N/A · 1 location(s) · University of Chicago · NCT01416714Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor
Phase 2 · 1 location(s) · Asan Medical Center · NCT05905887A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatini
Phase 3 · 124 location(s) · GlaxoSmithKline · NCT07218926PH 2 Pemigatinib in SDH-deficient GIST
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07434843Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
Phase 1 · 1 location(s) · University of California, San Diego · NCT07171203KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Lin
Phase 2 · 16 location(s) · Kumquat Biosciences Inc. · NCT07406633A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Phase 1/Phase 2 · 28 location(s) · Deciphera Pharmaceuticals, LLC · NCT05957367Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Strom
Phase 2 · 1 location(s) · Jian Li · NCT07559864A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors
Phase N/A · 1 location(s) · Fujian Medical University · NCT05938309Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT04933669A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Phase 1/Phase 2 · 4 location(s) · Cancer Research UK · NCT06380816Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Phase 2/Phase 3 · 32 location(s) · Ningbo Newbay Technology Development Co., Ltd · NCT07379047Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments
Phase 1 · 2 location(s) · Ono Pharmaceutical Co., Ltd. · NCT07618377Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2 · 3 location(s) · Centre Oscar Lambret · NCT05500391A Study of Olverembatinib in SDH-deficient GIST.
Phase 3 · 1 location(s) · Ascentage Pharma Group Inc. · NCT06640361Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
NA · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT06507683Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and U
Phase N/A · 1 location(s) · Fujian Medical University · NCT03716089A Study of HQP1351 in Patients With GIST or Other Solid Tumors
Phase 1 · 6 location(s) · Ascentage Pharma Group Inc. · NCT03594422Imatinib TDM in GIST
Phase 2 · 1 location(s) · Reema A. Patel · NCT05493215LRG GIST Patient Registry
Phase N/A · 1 location(s) · The Life Raft Group · NCT07697248DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizu
Phase 2 · 13 location(s) · Centre Leon Berard · NCT05152472Observational Registry Data on GIST Patients
Phase N/A · 1 location(s) · National Health Research Institutes, Taiwan · NCT03602092Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis
Phase N/A · 1 location(s) · Huazhong University of Science and Technology · NCT07078136Safety of Robotic Surgery for GISTs at Special Anatomic Sites
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07405125
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.